MONDAY, July 17, 2023 (HealthDay Now) — Parents now have a new long-acting drug to protect their children against respiratory syncytial virus (RSV), a common germ that hospitalizes as many as 3% of children under the age of 1 in the United States…
You may also like
About 4 in 5 kidney transplant candidates never reach...
Ambient AI is already in the exam room. Is agentic AI...
Dementia risk similar for poor quality hearing aids...
Understanding the psychological impact of weight...
People continue to search Google for obesity lifestyle...
Key takeaways from new guideline on central precocious...
About the author
David Miller
a pharmacist, a tech enthusiastic, who explored the Internet to gather all latest information pharma, biotech, healthcare and other related industries.